
Study links joint pain supplement to accelerating dementia
New research links glucosamine, a joint pain supplement, to a 25% higher likelihood of progression from mild cognitive impairment (MCI) to
23 Jun 2026

'Ophthalmic Drug Delivery' is a comprehensive compendium of ocular pharmaceutical research, emphasising industrial and regulatory requirements to translate innovations from




Auckland · 2-2 Aug
Gold Coast · 12-13 Sept
New Zealand International Convention Centre, Auckland · 1-1 Nov
Novotel Sunshine Coast, Queensland · 15-18 Jul
Suntec Convention Centre, Singapore · 24-26 Jul
Fiji · 25-26 Jul